These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26542559)

  • 1. DRUG DISCOVERY. A new dawn for cataracts.
    Quinlan RA
    Science; 2015 Nov; 350(6261):636-7. PubMed ID: 26542559
    [No Abstract]   [Full Text] [Related]  

  • 2. Ophthalmology: Cataracts dissolved.
    Hejtmancik JF
    Nature; 2015 Jul; 523(7562):540-1. PubMed ID: 26200338
    [No Abstract]   [Full Text] [Related]  

  • 3. Lanosterol reverses protein aggregation in cataracts.
    Zhao L; Chen XJ; Zhu J; Xi YB; Yang X; Hu LD; Ouyang H; Patel SH; Jin X; Lin D; Wu F; Flagg K; Cai H; Li G; Cao G; Lin Y; Chen D; Wen C; Chung C; Wang Y; Qiu A; Yeh E; Wang W; Hu X; Grob S; Abagyan R; Su Z; Tjondro HC; Zhao XJ; Luo H; Hou R; Jefferson J; Perry P; Gao W; Kozak I; Granet D; Li Y; Sun X; Wang J; Zhang L; Liu Y; Yan YB; Zhang K
    Nature; 2015 Jul; 523(7562):607-11. PubMed ID: 26200341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lanosterol on human cataract nucleus.
    Shanmugam PM; Barigali A; Kadaskar J; Borgohain S; Mishra DK; Ramanjulu R; Minija CK
    Indian J Ophthalmol; 2015 Dec; 63(12):888-90. PubMed ID: 26862091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. βB2 W151R mutant is prone to degradation, aggregation and exposes the hydrophobic side chains in the fourth Greek Key motif.
    Xu J; Wang H; Wang A; Xu J; Fu C; Jia Z; Yao K; Chen X
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166018. PubMed ID: 33246011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Evaluation, and Structure-Activity Relationship Study of Lanosterol Derivatives To Reverse Mutant-Crystallin-Induced Protein Aggregation.
    Yang X; Chen XJ; Yang Z; Xi YB; Wang L; Wu Y; Yan YB; Rao Y
    J Med Chem; 2018 Oct; 61(19):8693-8706. PubMed ID: 30153006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lanosterol and 25-hydroxycholesterol dissociate crystallin aggregates isolated from cataractous human lens via different mechanisms.
    Chen XJ; Hu LD; Yao K; Yan YB
    Biochem Biophys Res Commun; 2018 Dec; 506(4):868-873. PubMed ID: 30392915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological approaches to restoring lens transparency: Real world applications.
    Skinner C; Miraldi Utz V
    Ophthalmic Genet; 2017; 38(3):201-205. PubMed ID: 27648776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-based treatment strategies for cataract.
    Cetinel S; Unsworth L; Montemagno C
    J Glaucoma; 2014; 23(8 Suppl 1):S73-6. PubMed ID: 25275913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearing cataracts without surgery.
    Gundersen BB
    Lab Anim (NY); 2015 Oct; 44(10):367. PubMed ID: 26398599
    [No Abstract]   [Full Text] [Related]  

  • 11. Zebrafish (Danio rerio) Is an Economical and Efficient Animal Model for Screening Potential Anti-cataract Compounds.
    Liu CF; Ou-Yang Y; Huang CY; Jao SW; Kuo YK; Chen HC; Cheng SC; Wang NK; Chuang LH; Chen YH; Chen WY
    Transl Vis Sci Technol; 2022 Aug; 11(8):21. PubMed ID: 35994266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of monohydroxylated flavonoids on glycation-induced lens opacity and protein aggregation.
    Patil KK; Meshram RJ; Gacche RN
    J Enzyme Inhib Med Chem; 2016; 31(sup1):148-156. PubMed ID: 27149249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
    Kino R; Araya T; Arai T; Sohma Y; Kanai M
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiamyloidogenic Chemical/Biochemical-Based Designed Nanoparticle as Artificial Chaperone for Efficient Inhibition of Protein Aggregation.
    Pradhan N; Debnath K; Mandal S; Jana NR; Jana NR
    Biomacromolecules; 2018 Jun; 19(6):1721-1731. PubMed ID: 29742346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Beta-Amyloid Fibrillation by Luminescent Iridium(III) Complex Probes.
    Lu L; Zhong HJ; Wang M; Ho SL; Li HW; Leung CH; Ma DL
    Sci Rep; 2015 Sep; 5():14619. PubMed ID: 26419607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Green Tea Polyphenol Epigallocatechin-3-gallate on the Aggregation of αA(66-80) Peptide, a Major Fragment of αA-crystallin Involved in Cataract Development.
    Kumar V; Gour S; Peter OS; Gandhi S; Goyal P; Pandey J; Harsolia RS; Yadav JK
    Curr Eye Res; 2017 Oct; 42(10):1368-1377. PubMed ID: 28628342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the aggregation behavior of human islet amyloid polypeptide fragment by titanocene complexes.
    Du W; Gong G; Wang W; Xu J
    J Biol Inorg Chem; 2017 Oct; 22(7):1065-1074. PubMed ID: 28801867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.
    Francioso A; Punzi P; Boffi A; Lori C; Martire S; Giordano C; D'Erme M; Mosca L
    Bioorg Med Chem; 2015 Apr; 23(8):1671-83. PubMed ID: 25769517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synergistic effect between KLVFF and self-assembly chaperones on both disaggregation of beta-amyloid fibrils and reducing consequent toxicity.
    Qu A; Huang F; Li A; Yang H; Zhou H; Long J; Shi L
    Chem Commun (Camb); 2017 Jan; 53(7):1289-1292. PubMed ID: 28067349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing susceptibility to oxidative stress by cataract-causing crystallin mutations.
    Zhao WJ; Yan YB
    Int J Biol Macromol; 2018 Mar; 108():665-673. PubMed ID: 29222017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.